Summary
In a significant market movement during May 2026, iFAST Diagnostics was the subject of a vc funding. The transaction achieved a gross valuation of £4,999,996. Leading the round was Innovate UK grant, OKG Capital, Meridian Health Ventures (MHV), Qantx, existing subscribers, RAW Ventures, members of Cambridge Capital Group.
This transaction was brokered by an undisclosed advisor. The deal reflects ongoing market confidence within its sector.
Lead Investor / Acquirer
Innovate UK grant
Lead Investor / Acquirer
OKG Capital
Lead Investor / Acquirer
Meridian Health Ventures (MHV)
Lead Investor / Acquirer
Qantx
Lead Investor / Acquirer
existing subscribers
Lead Investor / Acquirer
RAW Ventures
Lead Investor / Acquirer
members of Cambridge Capital Group
Advising Broker
Undisclosed Firm
Related Deals in Healthcare & Biotech
Series A prioritisedOriginal Source
This funding round is sourced from the Tech.eu Funding Explorer. View the full record, investors, and citations there.
View on Tech.eu Funding ExplorerFunding data via Tech.eu Funding Explorer, licensed under CC BY 4.0. See our methodology.
AI Insight Lenses
ProAI-generated analysis from four professional perspectives. Powered by PE Deals.
Sign in to unlock AI Lenses
Sign in